Evaluation of the efficacy and safety of switching to tenofovir, emtricitabine, and rilpivirine in treatment-experienced patients

Laure Surgers, Nadia Valin, C. line Viala, Anders Boyd, Laurent Fonquernie, Pierre-Marie Girard, Laurence Morand-Joubert, Jean-Luc Meynard

Research output: Contribution to journalComment/Letter to the editorAcademic

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)e10-e12
JournalJournal of acquired immune deficiency syndromes (1999)
Volume68
Issue number1
DOIs
Publication statusPublished - 1 Jan 2015
Externally publishedYes

Keywords

  • Adenine/administration & dosage
  • Adult
  • Aged
  • Anti-HIV Agents/administration & dosage
  • Deoxycytidine/administration & dosage
  • Drug Therapy, Combination
  • Emtricitabine
  • Female
  • HIV Infections/drug therapy
  • Humans
  • Male
  • Middle Aged
  • Nitriles/administration & dosage
  • Organophosphonates/administration & dosage
  • Pyrimidines/administration & dosage
  • Rilpivirine
  • Tenofovir
  • Young Adult

Cite this